Erelzi
Jul 26, 2017
PRErelziTM
ErelziTM (etanercept) is a biosimilar to the Canadian authorized reference product, Enbrel®. ErelziTM is indicated for use in Rheumatoid Arthritis, Ankylosing Spondylitis and Juvenile Idiopathic Arthritis.
ErelziTM is the second Sandoz biosimilar available in Canada.
Click here to consult the monograph of ErelziTM
* ErelziTM is trademark owned or used under license by Sandoz Canada Inc.
** Enbrel® is a registered trademark of Amgen in Canada.
*** Sandoz Canada has not sought the approval of ErelziTM for the treatment of psoriatic arthritis or plaque psoriasis at this time.